SMLR 62.82 Stock Price Semler Scientific, Inc.
Range: | 20.88-76.98 | Vol Avg: | 332356 | Last Div: | 0 | Changes: | -2.78 |
Beta: | 0.92 | Cap: | 0.46B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Fri Feb 21 2014 | Empoloyees: | 92 |
CUSIP: | 81684M104 | CIK: | 0001554859 | ISIN: | US81684M1045 | Country: | US |
CEO: | Dr. Douglas Murphy-Chutorian M.D. | Website: | https://www.semlerscientific.com |
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.